| Shuo Li, MD | |
|
9300 E 29th St N Ste 206, Wichita, KS 67226-2183 | |
| (316) 685-1367 | |
| Not Available |
| Full Name | Shuo Li |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 11 Years |
| Location | 9300 E 29th St N Ste 206, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871926899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 04-42047 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wesley Medical Center | Wichita, KS | Hospital |
| William Newton Hospital | Winfield, KS | Hospital |
| Coffey County Hospital | Burlington, KS | Hospital |
| Hospital District #6 Patterson Health Center | Anthony, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wichita Radiological Group Prof Assoc | 6507762960 | 27 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.
Hot-button provisions in the Senate health Bill, such as the public option, cost controls and subsidies to expand coverage continue to get a lot of attention, while some interesting details have gone with little notice.
› Verified 4 days ago
| Entity Name | Wichita Radiological Group Prof Assoc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144256447 PECOS PAC ID: 6507762960 Enrollment ID: O20031208001045 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.
Hot-button provisions in the Senate health Bill, such as the public option, cost controls and subsidies to expand coverage continue to get a lot of attention, while some interesting details have gone with little notice.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shuo Li, MD 9300 E 29th St N Ste 206, Wichita, KS 67226-2183 Ph: (316) 685-1367 | Shuo Li, MD 9300 E 29th St N Ste 206, Wichita, KS 67226-2183 Ph: (316) 685-1367 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.
Hot-button provisions in the Senate health Bill, such as the public option, cost controls and subsidies to expand coverage continue to get a lot of attention, while some interesting details have gone with little notice.
› Verified 4 days ago
Karl Hamouche, Radiology Medicare: Medicare Enrolled Practice Location: 551 N Hillside St Ste 320, Wichita, KS 67214 Phone: 316-685-1367 | |
Dr. Larry C Graham Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-5050 Fax: 316-689-6192 | |
Tim Edward Stone, Radiology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2665 | |
Dr. Donald C S Tan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 817 N Emporia St, Via Christi Cancer Center, Wichita, KS 67214 Phone: 316-268-5927 | |
Elizabeth Perez-elmore, RN BSN Radiology Medicare: Not Enrolled in Medicare Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 | |
Mike Lam, DO Radiology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2635 | |
Dr. Timothy C Benning, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-6173 |